 In September 1972, Jordan became a Visiting Scientist at the Worcester Foundation for Experimental Biology, Massachusetts.While there he began researching the idea that tamoxifen, a selective estrogen receptor modulator (SERM), could block estrogen receptors in breast tumors.Estrogen receptors in breast tumors attract estrogen which is then absorbed into the cancerous cell and encourages the cell to divide, causing the cancer to grow.